The human epidermal growth factor receptor HER2 provides critical signaling for cancer cell growth, survival, and proliferation.39 The majority of endometrial cancers, which over-express HER2 are mainly serous or TP53-mutated cancers, including carcinosarcomas. This evidence concerns the gene TP53 and endometrial cancer.